Search hospitals > Texas > San Antonio
Novartis Investigative Site
Claim this profileSan Antonio, Texas 78229
Global Leader in Postoperative Pain
Global Leader in Multiple Sclerosis
Conducts research for Diabetes
Conducts research for Non-alcoholic Fatty Liver Disease
Conducts research for Fatty Liver Disease
174 reported clinical trials
8 medical researchers
Summary
Novartis Investigative Site is a medical facility located in San Antonio, Texas. This center is recognized for care of Postoperative Pain, Multiple Sclerosis, Diabetes, Non-alcoholic Fatty Liver Disease, Fatty Liver Disease and other specialties. Novartis Investigative Site is involved with conducting 174 clinical trials across 131 conditions. There are 8 research doctors associated with this hospital, such as Nitendra Agarwal, Hernan Alfonso Salazar, Grant Garbo, MD, and EMANUEL PHILIP DE NOIA.Top PIs
Nitendra AgarwalEndeavor Clinical Trials1 year of reported clinical research
Studies Obesity
Studies Cardiovascular Disease
7 reported clinical trials
8 drugs studied
Hernan Alfonso SalazarEndeavor Clinical Trials4 years of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
2 reported clinical trials
3 drugs studied
Grant Garbo, MDEndeavor Clinical Trials1 year of reported clinical research
Studies Anemia
Studies Chronic Kidney Disease
2 reported clinical trials
4 drugs studied
EMANUEL PHILIP DE NOIAEndeavor Clinical Trials1 year of reported clinical research
Studies High Triglycerides
1 reported clinical trial
2 drugs studied
Clinical Trials running at Novartis Investigative Site
Obesity
Multiple Sclerosis
Chronic Urticaria
Cardiovascular Disease
Gout
Hives
Bunions
Type 2 Diabetes
Chronic Kidney Disease
Postoperative Pain
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
LY3305677
for Obesity
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Recruiting0 awards Phase 23 criteria
LY3841136
for Obesity
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight. The study will last about 64 weeks and may include up to 13 visits.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in San Antonio, Texas. This center is recognized for care of Postoperative Pain, Multiple Sclerosis, Diabetes, Non-alcoholic Fatty Liver Disease, Fatty Liver Disease and other specialties. Novartis Investigative Site is involved with conducting 174 clinical trials across 131 conditions. There are 8 research doctors associated with this hospital, such as Nitendra Agarwal, Hernan Alfonso Salazar, Grant Garbo, MD, and EMANUEL PHILIP DE NOIA.